UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Strand transfer inhibitors of HIV-1 integrase: Bringing IN a new era of antiretroviral therapy

Antiviral research, 2010, Vol.85 (1), p.101-118

2010

Volltextzugriff (PDF)

Impact of Primary Elvitegravir Resistance-Associated Mutations in HIV-1 Integrase on Drug Susceptibility and Viral Replication Fitness

Antimicrobial Agents and Chemotherapy, 2013-06, Vol.57 (6), p.2654-2663

2013

Volltextzugriff (PDF)

Resistance mutations outside the integrase coding region have an effect on human immunodeficiency virus replicative fitness but do not affect its susceptibility to integrase strand transfer inhibitors

PloS one, 2013-06, Vol.8 (6), p.e65631

2013

Volltextzugriff (PDF)

Prevalence, genotypic associations and phenotypic characterization of K65R, L74V and other HIV-1 RT resistance mutations in a commercial database

Antiviral therapy, 2008-01, Vol.13 (2), p.189-197

2008

Volltextzugriff (PDF)

Low level of the K103N HIV-1 above a threshold is associated with virological failure in treatment-naive individuals undergoing efavirenz-containing therapy

AIDS (London), 2011-01, Vol.25 (3), p.325-333

2011

Volltextzugriff (PDF)

In vitro resistance selections using elvitegravir, raltegravir, and two metabolites of elvitegravir M1 and M4

Antiviral research, 2012-02, Vol.93 (2), p.288-296

2012

Volltextzugriff (PDF)

Development of HIV-1 drug resistance through 144 weeks in antiretroviral-naïve subjects on emtricitabine, tenofovir disoproxil fumarate, and efavirenz compared with lamivudine/zidovudine and efavirenz in study GS-01-934

Journal of acquired immune deficiency syndromes (1999), 2009-10, Vol.52 (2), p.209-221

2009

Volltextzugriff (PDF)

Week 144 resistance analysis of elvitegravir/cobicistat/emtricitabine/tenofovir DF versus efavirenz/emtricitabine/tenofovir DF in antiretroviral-naive patients

Antiviral therapy, 2015-01, Vol.20 (3), p.317-327

2015

Volltextzugriff (PDF)

Trends in HIV-1 reverse transcriptase resistance-associated mutations and antiretroviral prescription data from 2003-2010

Antiviral therapy, 2012-01, Vol.17 (6), p.993-999

2012

Volltextzugriff (PDF)

Structure-Based Design of an RNA-Binding Zinc Finger

Proceedings of the National Academy of Sciences - PNAS, 1999-08, Vol.96 (17), p.9521-9526

1999

Volltextzugriff (PDF)

Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase—Structure–activity relationships and crystallographic analysis

Bioorganic & medicinal chemistry, 2008-02, Vol.18 (3), p.1131-1134

2008

Volltextzugriff (PDF)

Patterns of resistance emerging in HIV-1 from antiretroviral-experienced patients undergoing intensification therapy with tenofovir disoproxil fumarate

Journal of acquired immune deficiency syndromes (1999), 2004-11, Vol.37 (3), p.1340-1350

2004

Volltextzugriff (PDF)

Properties of the Plasmodium falciparum homologue of a protective vaccine candidate of Plasmodium yoelii

Molecular and biochemical parasitology, 2001-11, Vol.118 (1), p.41-48

2001

Volltextzugriff (PDF)

HIV type 1 integrase inhibitors: from basic research to clinical implications

AIDS reviews, 2008-07, Vol.10 (3), p.172-189

2008

Volltextzugriff (PDF)

Nuclear Magnetic Resonance Solution Structure of the Human Hsp40 (HDJ-1) J-domain

Journal of molecular biology, 1996-07, Vol.260 (2), p.224-235

1996

Volltextzugriff (PDF)

Conservation of structural motifs and antigenic diversity in the Plasmodium falciparum merozoite surface protein-3 (MSP-3)

Molecular and biochemical parasitology, 1997-12, Vol.90 (1), p.21-31

1997

Volltextzugriff (PDF)

The use of tenofovir disoproxil fumarate for the treatment of nucleoside-resistant HIV-1

Journal of antimicrobial chemotherapy, 2003-02, Vol.51 (2), p.219-223

2003

Volltextzugriff (PDF)

Switching to the single-tablet regimen of elvitegravir, cobicistat, emtricitabine, and tenofovir DF from non-nucleoside reverse transcriptase inhibitor plus coformulated emtricitabine and tenofovir DF regimens: Week 96 results of STRATEGY-NNRTI

HIV clinical trials, 2017-07, Vol.18 (4), p.141-148

2017

Volltextzugriff (PDF)

The Paucity of Grants among Young Scientists

Science (American Association for the Advancement of Science), 2002-12, Vol.298 (5602), p.2328-2329

2002

Volltextzugriff (PDF)

Week 144 Resistance Analysis of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Atazanavir+Ritonavir+Emtricitabine/Tenofovir DF in Antiretroviral-Naïve Patients

HIV clinical trials, 2014-09, Vol.15 (5), p.218-230

2014

Volltextzugriff (PDF)

Strand transfer inhibitors of HIV-1 integrase: Bringing IN a new era of antiretroviral therapy: Twenty-five Years of Antiretroviral Drug Development: Progress and Prospects

Antiviral research, 2010, Vol.85 (1), p.101-118

2010

Volltextzugriff (PDF)

A putative Plasmodium falciparum exported serine/threonine protein kinase

Molecular and biochemical parasitology, 1997-03, Vol.85 (1), p.41-51

1997

Volltextzugriff (PDF)

Reduced Emergence of the M184V/I Resistance Mutation When Antiretroviral-Naïve Subjects Use Emtricitabine Versus Lamivudine in Regimens Composed of Two NRTIs Plus the NNRTI Efavirenz

HIV clinical trials, 2011-04, Vol.12 (2), p.61-70

2011

Volltextzugriff (PDF)

Solution structure of a polypeptide containing four heptad repeat units from a merozoite surface antigen of Plasmodium falciparum

Biochemistry (Easton), 1995-03, Vol.34 (11), p.3479-3491

1995

Volltextzugriff (PDF)

A second merozoite surface protein (MSP-4) of Plasmodium falciparum that contains an epidermal growth factor-like domain

Infection and Immunity, 1997-11, Vol.65 (11), p.4460-4467

1997

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Humans
(23)
Life Sciences & Biomedicine
(23)
Infectious Diseases
(17)
Biological And Medical Sciences
(15)
Hiv Infections - Drug Therapy
(15)
Hiv-1 - Drug Effects
(15)
Medical Sciences
(14)
Drug Resistance, Viral
(12)
Hiv
(11)
Human Viral Diseases
(11)
Viral Diseases
(11)
Virology
(11)
Adenine - Analogs & Derivatives
(10)
Hiv Infections - Virology
(10)
Hiv-1 - Genetics
(10)
Mutation
(10)
Pharmacology & Pharmacy
(10)
Tenofovir
(10)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Strand transfer inhibitors of HIV-1 integrase: Bringing IN a new era of antiretroviral therapy

Impact of Primary Elvitegravir Resistance-Associated Mutations in HIV-1 Integrase on Drug Susceptibility and Viral Replication Fitness

Resistance mutations outside the integrase coding region have an effect on human immunodeficiency virus replicative fitness but do not affect its susceptibility to integrase strand transfer inhibitors

Prevalence, genotypic associations and phenotypic characterization of K65R, L74V and other HIV-1 RT resistance mutations in a commercial database

Low level of the K103N HIV-1 above a threshold is associated with virological failure in treatment-naive individuals undergoing efavirenz-containing therapy

In vitro resistance selections using elvitegravir, raltegravir, and two metabolites of elvitegravir M1 and M4

Development of HIV-1 drug resistance through 144 weeks in antiretroviral-naïve subjects on emtricitabine, tenofovir disoproxil fumarate, and efavirenz compared with lamivudine/zidovudine and efavirenz in study GS-01-934

Week 144 resistance analysis of elvitegravir/cobicistat/emtricitabine/tenofovir DF versus efavirenz/emtricitabine/tenofovir DF in antiretroviral-naive patients

Trends in HIV-1 reverse transcriptase resistance-associated mutations and antiretroviral prescription data from 2003-2010

Structure-Based Design of an RNA-Binding Zinc Finger

Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase—Structure–activity relationships and crystallographic analysis

Patterns of resistance emerging in HIV-1 from antiretroviral-experienced patients undergoing intensification therapy with tenofovir disoproxil fumarate

Properties of the Plasmodium falciparum homologue of a protective vaccine candidate of Plasmodium yoelii

HIV type 1 integrase inhibitors: from basic research to clinical implications

Nuclear Magnetic Resonance Solution Structure of the Human Hsp40 (HDJ-1) J-domain

Conservation of structural motifs and antigenic diversity in the Plasmodium falciparum merozoite surface protein-3 (MSP-3)

The use of tenofovir disoproxil fumarate for the treatment of nucleoside-resistant HIV-1

Switching to the single-tablet regimen of elvitegravir, cobicistat, emtricitabine, and tenofovir DF from non-nucleoside reverse transcriptase inhibitor plus coformulated emtricitabine and tenofovir DF regimens: Week 96 results of STRATEGY-NNRTI

The Paucity of Grants among Young Scientists

Week 144 Resistance Analysis of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Atazanavir+Ritonavir+Emtricitabine/Tenofovir DF in Antiretroviral-Naïve Patients

Strand transfer inhibitors of HIV-1 integrase: Bringing IN a new era of antiretroviral therapy: Twenty-five Years of Antiretroviral Drug Development: Progress and Prospects

A putative Plasmodium falciparum exported serine/threonine protein kinase

Reduced Emergence of the M184V/I Resistance Mutation When Antiretroviral-Naïve Subjects Use Emtricitabine Versus Lamivudine in Regimens Composed of Two NRTIs Plus the NNRTI Efavirenz

Solution structure of a polypeptide containing four heptad repeat units from a merozoite surface antigen of Plasmodium falciparum

A second merozoite surface protein (MSP-4) of Plasmodium falciparum that contains an epidermal growth factor-like domain

Suchergebnisse filtern